 |
12 Diseases |  |
0 Trials |
|
0 Trials |  |
3 News |  |
- ALRN-5281 / Aileron
Enrollment change: Phase 1 Safety Study of ALRN-5281 in Healthy Subjects (clinicaltrials.gov) - May 28, 2013
P1, N=33, Completed, Sponsor: Aileron Therapeutics
N=48 --> 33
- | ALRN-5281 / Aileron
Trial completion: Phase 1 Safety Study of ALRN-5281 in Healthy Subjects (clinicaltrials.gov) - May 28, 2013
P1, N=33, Completed, Sponsor: Aileron Therapeutics
N=48 --> 33 Active, not recruiting --> Completed
- | ALRN-5281 / Aileron
New P1 trial: Phase 1 Safety Study of ALRN-5281 in Healthy Subjects (clinicaltrials.gov) - Jan 23, 2013
P1, N=33, Completed, Sponsor: Aileron Therapeutics